INmune Bio, Inc. (INMB) Misses Q3 EPS by 8c

INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.60), $0.08 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Vista Oil & Gas, S.A.B. de C.V. (VIST) 1300 contracts of December 85 puts trade
• TripAdvisor (TRIP) in the money January 13 puts active